• 9607 Citations
  • 31 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Cutaneous melanoma, version 2.2019

Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., Daniels, G. A., DiMaio, D., Fields, R. C., Fleming, M. D., Freeman, M., Galan, A., Gastman, B., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Nath, S., Olszanski, A. J., Ott, P. & 10 others, Gupta, A. P., Ross, M. I., Salama, A. K., Skitzki, J., Sosman, J., Swetter, S. M., Tanabe, K. K., Wuthrick, E., McMillian, N. R. & Engh, A. M., Apr 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 4, p. 367-402 36 p.

Research output: Contribution to journalReview article

Open Access
41 Scopus citations
2018

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Sonbol, M. B., Firwana, B., Hilal, T., Wang, Z., Almader-Douglas, D., Joseph, R. W. & Ho, T. H., Jun 2018, In : European Urology Oncology. 1, 2, p. 101-108 8 p.

Research output: Contribution to journalReview article

2 Scopus citations
2017

Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice

Joseph, R. W., Chatta, G. & Vaishampayan, U., Apr 1 2017, In : Urologic Oncology: Seminars and Original Investigations. 35, 4, p. 142-148 7 p.

Research output: Contribution to journalReview article

8 Scopus citations
2016

Patient-derived tumor xenograft models for melanoma drug discovery

Harris, A. L., Joseph, R. W. & Copland, J. A. III., Sep 1 2016, In : Expert Opinion on Drug Discovery. 11, 9, p. 895-906 12 p.

Research output: Contribution to journalReview article

7 Scopus citations

Prolonged benefit from ipilimumab correlates with improved outcomes from subsequent pembrolizumab

Shreders, A., Joseph, R. W., Peng, C., Ye, F., Zhao, S., Puzanov, I., Sosman, J. A. & Johnson, D. B., Jul 1 2016, In : Cancer immunology research. 4, 7, p. 569-573 5 p.

Research output: Contribution to journalReview article

10 Scopus citations
2014

Vemurafenib: An evidence-based review of its clinical utility in the treatment of metastatic melanoma

Swaika, A., Crozier, J. A. & Joseph, R. W., Jun 16 2014, In : Drug Design, Development and Therapy. 8, p. 775-787 13 p.

Research output: Contribution to journalReview article

31 Scopus citations
2012

Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma

Joseph, R. W., Sullivan, R. J., Harrell, R., Stemke-Hale, K., Panka, D., Manoukian, G., Percy, A., Bassett, R. L., Ng, C. S., Radvanyi, L., Hwu, P., Atkins, M. B. & Davies, M. A., Jan 1 2012, In : Journal of Immunotherapy. 35, 1, p. 66-72 7 p.

Research output: Contribution to journalReview article

85 Scopus citations

Therapy for metastatic melanoma: The past, present, and future

Finn, L., Markovic, S. N. & Joseph, R. W., Mar 2 2012, In : BMC Medicine. 10, 23.

Research output: Contribution to journalReview article

135 Scopus citations
2008

Chronic Graft-Versus-Host Disease after allogeneic stem cell transplantation: Challenges in prevention, science, and supportive care

Joseph, R. W., Couriel, D. R. & Komanduri, K. V., Dec 1 2008, In : Journal of Supportive Oncology. 6, 8, p. 361-372 12 p.

Research output: Contribution to journalReview article

22 Scopus citations